An Act amending the act of May 13, 2008 (P.L.139, No.14), known as the Cancer Drug Repository Program Act, further providing for title and short title of act, for definitions, for establishment, for restocking and dispensing of cancer drugs, for storage, distribution and fees and for immunity; providing for annual report, for list of approved participating pharmacies and for limitations; further providing for regulations; and imposing duties on the State Board of Pharmacy.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 3 Compare versions History 14 Sponsors

Jun 25, 2026 · Senate

Second consideration

Jun 25, 2026 · Senate

Re-referred to Appropriations

Jun 24, 2026 · Senate

Reported as committed

Jun 24, 2026 · Senate

First consideration

Jun 5, 2026 · Senate

Referred to Health & Human Services

Jun 3, 2026 · House

Re-reported as committed

Jun 3, 2026 · House

Third consideration and final passage

Jun 2, 2026 · House

Second consideration, with amendments

Jun 2, 2026 · House

Re-committed to Appropriations

Jun 1, 2026 · House

Removed from table

Apr 9, 2025 · House

Reported as amended

Apr 9, 2025 · House

First consideration

Apr 9, 2025 · House

Laid on the table

Jan 14, 2025 · House

Referred to Health

PASSAGE PROBABILITY

10.9% Unlikely

Why this number

Stage base Passed First Chamber — base rate 19%, measured from PA's completed sessions
Momentum +6 75/100 from the pace of recorded action
Time since last action -14 107 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.